Verilumia 
Ultragenyx Angelman drug fails late-stage trial, shares plunge
Ultragenyx Pharmaceutical announced on Wednesday that its experimental drug for Angelman syndrome failed to meet its main goals in a pivotal late-stage trial, a major setback for the company and the patient community awa...
